COLLINK.3D
LIVE

Serial Number

79347817

Owner

CollPlant Ltd.

Attorney

Jeffrey A. Smith

Filing Date

Mar 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

COLLINK.3D Trademark

Serial Number: 79347817 • Registration: 7451851

COLLINK.3D is a trademark filed by CollPlant Ltd. on March 27, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CollPlant Ltd. (3 trademarks)

4 Oppenheimer St.

Entity Type: 99

Trademark Details

Filing Date

March 27, 2022

Registration Date

July 23, 2024

Published for Opposition

May 7, 2024

Goods & Services

Biological preparations for use in pharmaceutical, medical and veterinary industry, namely, for personalized medicine use in the nature of treatment of autoimmune diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, microbial disorders and diseases, fungal disorders and diseases, inflammatory disorders and diseases, vaginal and rectal disorders and diseases, ear and eye disorders, orthopedic diseases and disorders, central and peripheral nervous system diseases and disorders, endocrine system diseases and disorders, neurodegenerative diseases and disorders, nasal pharyngeal diseases and disorder, cancer, infectious diseases and viral infections; bioadhesives, namely, medical adhesives intended for closure of wounds and gaps and for other medical fixing, namely, binding internal tissue; bio-printed materials for use in organ transplantation, namely, biological soft, hard, skin and bone tissue grafts and cultures, implantable scaffolds comprised of living tissue or cells, organ implants comprised of living tissue or cells, intended for subsequent implantation, and bio-inks comprised of living cells which stimulates tissue regeneration and support cell adherence and proliferation for medical use; biological implants, namely, biological soft and hard human connective tissue intended for subsequent implantation and organ implants comprised of living tissue or cells, intended for subsequent implantation; biological preparations for use in cell culture applications in the fields of pharmaceutical, medical, veterinary and aesthetic medicine use, namely, cell culture media for cultivating animal or human tissue or cells

Chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; chemicals for use in organ transplantation, namely, chemicals for the manufacture of 3D printed scaffolds, tissues and organs, not for medical purposes; bio-chemicals for use in pharmaceutical, medical, cosmetics, veterinary and aesthetic industries; bio-chemicals for use in organ transplantation, namely, bio-chemicals for the manufacture of 3D printed scaffolds, tissues and organs, not for medical purposes; biological preparations for use in industry and science, other than for medical, veterinary, cosmetics or aesthetic use; biological preparations for use in cosmetics and aesthetic industry; biological preparations for use in industry, namely, bio-printable materials in the nature of cells and bio-inks being bio-chemicals for use in cosmetics and aesthetic industries, not for medical use or veterinary purposes; biological preparations for use in cell cultures for applications in the field of cosmetics, not for medical or veterinary use

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Jan 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 4, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2024 R.PR
NOTIFICATION PROCESSED BY IB
May 7, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 17, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2024 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 13, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 24, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 24, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 13, 2023 GNFN
FINAL REFUSAL E-MAILED
Sep 13, 2023 GNFR
FINAL REFUSAL WRITTEN
Sep 13, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 12, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 11, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 11, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 18, 2022 REPR